The shares were acquired by Quvadec pursuant to an agreement entered into between Quva and the De Cuyper Family on 25 November 2021 of which the conditions precedent have in the meantime been fulfilled. The price paid by Quvadec for the Resilux shares acquired from the De Cuyper Family equals EUR 235 per share.
As a result of the Acquisition, Quvadec has crossed the threshold for launching a mandatory tender offer for the remaining shares of Resilux, as provided for by the Belgian Royal Decree of 27 April 2007 on public tender offers.
This announcement does not constitute formal notification of a public tender offer within the meaning of Article 7 of the Belgian Royal Decree of 27 April 2007 on public tender offers.